☆ 4.8 Article

Checkpoint Nano-PROTACs for Activatable Cancer Photo-Immunotherapy

ADVANCED MATERIALS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Chemistry, Multidisciplinary

Light-Triggered Efficient Sequential Drug Delivery of Biomimetic Nanosystem for Multimodal Chemo-, Antiangiogenic, and Anti-MDSC Therapy in Melanoma

Xing Lai et al.

Summary: In order to improve cancer therapy, a nanosystem that can sequentially deliver drugs targeting different locations inside and outside tumor cells is desired. This study developed a light-triggered sequential delivery strategy using liposomal formulation to release drugs in a controlled manner, resulting in improved antiangiogenic therapy and immunosuppression reversal in the tumor microenvironment.

ADVANCED MATERIALS (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

Smart Nano-PROTACs Reprogram Tumor Microenvironment for Activatable Photo-metabolic Cancer Immunotherapy

Chi Zhang et al.

Summary: This study introduces smart nano-proteolysis targeting chimeras for photo-metabolic cancer immunotherapy, reprogramming the immunosuppressive tumor microenvironment by utilizing phototherapeutic ablation and cancer-specific protein degradation.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

Semiconducting Polymer Nano-regulators with Cascading Activation for Photodynamic Cancer Immunotherapy

Shasha He et al.

Summary: This study introduces a novel semiconducting polymer nano-regulator (SPNT) that can produce singlet oxygen under near-infrared photoirradiation, inducing immunogenic apoptosis. By regulating immune-related factors, SPNT-mediated combination photodynamic immunotherapy successfully suppressed tumor growth and lung metastasis.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

A Dual-Color Fluorescent Probe Allows Simultaneous Imaging of Main and Papain-like Proteases of SARS-CoV-2-Infected Cells for Accurate Detection and Rapid Inhibitor Screening

Yong Cheng et al.

Summary: Researchers have developed a dual-color probe for the simultaneous detection of the main protease (MPpro) and papain-like protease (PLpro) of SARS-CoV-2. This probe produces fluorescence from two different fluorophores, which can be used for rapid screening of antiviral inhibitors.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2022)

添加到收藏夹

Review Chemistry, Multidisciplinary

Delivery strategies in treatments of leukemia

Tianyuan Ci et al.

Summary: This review discusses the current state and advances in anti-leukemia drugs and therapies, with a focus on the development of drug delivery systems for leukemia treatment. These delivery systems improve the pharmacokinetics of drugs in vivo, targeting specific cells or tumor microenvironment and reversing drug resistance, leading to enhanced tumor elimination and reduced adverse effects.

CHEMICAL SOCIETY REVIEWS (2022)

添加到收藏夹

Review Biotechnology & Applied Microbiology

PROTAC targeted protein degraders: the past is prologue

Miklos Bekes et al.

Summary: Targeted protein degradation (TPD) is a new therapeutic modality that can tackle disease-causing proteins which are difficult to target with conventional small molecules. PROTAC molecules, utilizing the ubiquitin-proteasome system to degrade target proteins, has achieved clinical proof-of-concept and attracted significant industry activity. Future directions include identifying target classes suitable for TPD, expanding the use of ubiquitin ligases for precision medicine, and extending the modality beyond oncology.

NATURE REVIEWS DRUG DISCOVERY (2022)

添加到收藏夹

Review Nanoscience & Nanotechnology

Regulating trained immunity with nanomedicine

Mandy M. T. van Leent et al.

Summary: This Review discusses nanomedicine platforms to therapeutically regulate trained immunity for the treatment of various conditions, including cancer, inflammation and infection.

NATURE REVIEWS MATERIALS (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

Activatable Cancer Sono-Immunotherapy using Semiconducting Polymer Nanobodies

Ziling Zeng et al.

Summary: This study reports the development of semiconducting polymers as efficient sonosensitizers and the further development of sono-immunotherapeutic nanobodies. The strategy can achieve immunogenic cell death, release of anti-CTLA-4 antibodies, and promote tumor-killing function through sono-irradiation, providing important insights for precise spatiotemporal control over immunotherapy.

ADVANCED MATERIALS (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

Protease-Responsive Peptide-Conjugated Mitochondrial-Targeting AIEgens for Selective Imaging and Inhibition of SARS-CoV-2-Infected Cells

Yong Cheng et al.

Summary: This study reports a responsive, mitochondrial-targeting, modular-peptide-conjugated probe for selective imaging and inhibition of SARS-CoV-2-infected cells through enzyme-instructed self-assembly and aggregation-induced emission effect. This strategy may have value for selective detection and treatment of SARS-CoV-2-infected cells.

ACS NANO (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Catalytical nano-immunocomplexes for remote-controlled sono-metabolic checkpoint trimodal cancer therapy

Chi Zhang et al.

Summary: The authors have developed a pH-responsive and sono-irradiation activatable nanosystem for sono-metabolic cancer immunotherapy, functionalized with anti-PD-L1 and adenosine deaminase. This system can efficiently activate immune effector cells and inhibit immune suppressor cells.

NATURE COMMUNICATIONS (2022)

添加到收藏夹

Review Chemistry, Multidisciplinary

PROTACs: past, present and future

Ke Li et al.

Summary: PROTACs are a type of molecules with novel event-driven mechanism, offering multiple advantages over traditional inhibitors, such as catalytic nature and targeted protein degradation, which may lead to improved therapeutic outcomes with reduced toxicity. However, further research and development efforts are needed to fully explore their potential.

CHEMICAL SOCIETY REVIEWS (2022)

添加到收藏夹

Review Chemistry, Multidisciplinary

Challenges and Opportunities in Cancer Drug Resistance

Richard A. Ward et al.

Summary: Recent years have seen significant progress in targeted cancer therapies, but drug resistance remains a common challenge. Researchers are exploring new approaches to overcome resistance, such as increasing drug selectivity and potency, using alternative chemical structures, changing mechanisms of action, and targeting allosteric pockets.

CHEMICAL REVIEWS (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Activatable Polymer Nanoenzymes for Photodynamic Immunometabolic Cancer Therapy

Ziling Zeng et al.

Summary: This study introduces an organic polymer nanoenzyme (SPNK) with near-infrared (NIR) photoactivatable immunotherapeutic effects for photodynamic immunometabolic therapy. By generating singlet oxygen (O-1(2)) upon NIR photoirradiation, SPNK induces immunogenic cell death of cancer and degrades immunosuppressive kynurenine (Kyn), ultimately promoting effector T cell proliferation and infiltration, enhancing systemic antitumor T cell immunity, and inhibiting both primary and distant tumors in living mice.

ADVANCED MATERIALS (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Hallmarks of response, resistance, and toxicity to immune checkpoint blockade

Golnaz Morad et al.

Summary: This passage discusses the unprecedented advances in cancer treatment with immune checkpoint blockade (ICB), highlighting the critical need for insights into factors intrinsic and extrinsic to the host that impact ICB response and toxicity. There has been substantial progress in understanding the impact of host-intrinsic factors and the exposome on host physiology and response to treatment, representing the hallmarks of response, resistance, and toxicity to ICB in current day.

CELL (2021)

添加到收藏夹

Review Oncology

Beyond conventional immune-checkpoint inhibition - novel immunotherapies for renal cell carcinoma

David A. Braun et al.

Summary: The management of advanced-stage renal cell carcinoma has been transformed by the development of immune-checkpoint inhibitors (ICIs). However, most patients do not derive durable clinical benefit from these agents. Innovations in immunotherapy for RCC, including ICIs with novel targets, are now in clinical development.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

添加到收藏夹

Article Nanoscience & Nanotechnology

T lymphocyte membrane-decorated epigenetic nanoinducer of interferons for cancer immunotherapy

Yihui Zhai et al.

Summary: Researchers have developed a novel nanoparticle platform that enhances tumor immunity while reducing immunosuppression. This platform effectively increases levels of IFNs within the tumor and inhibits tumor growth.

NATURE NANOTECHNOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Semiconducting polymer nano-PROTACs for activatable photo-immunometabolic cancer therapy

Chi Zhang et al.

Summary: Proteolysis targeting chimeras (PROTACs) offer an alternative way to modulate protein homeostasis for cancer therapy, but existing PROTACs may have uncontrollable protein degradation and off-target side effects. This study presents a semiconducting polymer nano-PROTAC (SPNpro) with phototherapeutic and activatable protein degradation abilities for photo-immunometabolic cancer therapy. SPNpro can generate singlet oxygen under NIR photoirradiation to eradicate tumor cells and activate protein degradation specifically in response to a cancer biomarker, enhancing tumor immunogenicity.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

PROTACs technology for targeting non-oncoproteins: Advances and perspectives

Chao Wang et al.

Summary: PROTACs are a novel technology for targeted protein degradation with potential applications in various disease areas, sparking global interest.

BIOORGANIC CHEMISTRY (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Targeted Protein Degradation through Fast Optogenetic Activation and Its Application to the Control of Cell Signaling

Amy Ryan et al.

Summary: The development of optically triggered protein degradation methodologies allows for the study of dynamic protein functions that are difficult to probe with traditional genetic techniques. The novel light-controlled peptide degron design enables optical control of N-degron recognition by an E3 ligase, leading to ubiquitination and proteasomal degradation of target proteins. This approach demonstrates broad applicability and provides virtually complete, light-triggered protein degradation on a second to minute time scale.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Aptamer-Based Logic Computing Reaction on Living Cells to Enable Non-Antibody Immune Checkpoint Blockade Therapy

Yu Yang et al.

Summary: The development of an aptamer-based logic computing reaction allows for precise and sustained immune checkpoint blockade therapy on the surface of cancer cells without the need for antibodies. Using a bioorthogonal reaction, aptamers are conjugated on the living cell surface to trigger a T cell-mediated antitumor immunotherapy, significantly prolonging overall mouse survival.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Degradation from the outside in: Targeting extracellular and membrane proteins for degradation through the endolysosomal pathway

Green Ahn et al.

Summary: Targeted protein degradation (TPD) is a promising strategy to remove deleterious proteins for therapeutic benefit and to probe biological pathways. Various technologies have been developed to degrade challenging cytosolic targets, but there is a need for approaches to degrade extracellular and membrane proteins. Recent advancements in technology, such as lysosome-targeting chimeras (LYTACs), show potential in degrading both secreted and membrane-anchored targets.

CELL CHEMICAL BIOLOGY (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

TLR7/8 Agonist and SHP2 Inhibitor Loaded Nanoparticle Enhances Macrophage Immunotherapy Efficacy

Vaishali Malik et al.

Summary: The engineered nanoparticle can efficiently repolarize M2 macrophages to M1 phenotype and simultaneously block CD47-SIRPa interactions, enhancing the efficacy of macrophage immunotherapy.

ADVANCED THERAPEUTICS (2021)

添加到收藏夹

Review Oncology

Advancing targeted protein degradation for cancer therapy

Brandon Dale et al.

Summary: The development of small-molecule degraders such as proteolysis-targeting chimeras (PROTACs) has enabled the targeting of previously considered undruggable oncoproteins. This review discusses recent advances in the field, with a focus on opportunities and challenges for future development.

NATURE REVIEWS CANCER (2021)

添加到收藏夹

Review Immunology

Top 10 Challenges in Cancer Immunotherapy

Priti S. Hegde et al.

IMMUNITY (2020)

添加到收藏夹

Article Oncology

Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges

John D. Martin et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Targeting SHP2 as a promising strategy for cancer immunotherapy

Qianqian Liu et al.

PHARMACOLOGICAL RESEARCH (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Dual pH-sensitive nanodrug blocks PD-1 immune checkpoint and uses T cells to deliver NF-κB inhibitor for antitumor immunotherapy

Zecong Xiao et al.

SCIENCE ADVANCES (2020)

添加到收藏夹

Article Oncology

Allosteric Inhibition of SHP2 Stimulates Antitumor Immunity by Transforming the Immunosuppressive Environment

Elsa Quintana et al.

CANCER RESEARCH (2020)

添加到收藏夹

Review Cell Biology

Immune checkpoint signaling and cancer immunotherapy

Xing He et al.

CELL RESEARCH (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti-PD-L1 immunotherapy

Zhaoting Li et al.

SCIENCE ADVANCES (2020)

添加到收藏夹

Article Chemistry, Multidisciplinary

Targeted Degradation of Transcription Coactivator SRC-1 through the N-Degron Pathway

Yeongju Lee et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)

添加到收藏夹

Review Oncology

Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors

Lorenzo Galluzzi et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2020)

添加到收藏夹

Article Nanoscience & Nanotechnology

Proton-driven transformable nanovaccine for cancer immunotherapy

Ningqiang Gong et al.

NATURE NANOTECHNOLOGY (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Targeted degradation of immune checkpoint proteins: emerging strategies for cancer immunotherapy

Jie Xu et al.

ONCOGENE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

An allosteric interaction controls the activation mechanism of SHP2 tyrosine phosphatase

Massimiliano Anselmi et al.

SCIENTIFIC REPORTS (2020)

添加到收藏夹

Review Chemistry, Multidisciplinary

Molecular and nanoengineering approaches towards activatable cancer immunotherapy

Chi Zhang et al.

CHEMICAL SOCIETY REVIEWS (2020)

添加到收藏夹

Review Immunology

Tumour-intrinsic resistance to immune checkpoint blockade

Anusha Kalbasi et al.

NATURE REVIEWS IMMUNOLOGY (2020)

添加到收藏夹

Review Oncology

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance

Filipe Martins et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Checkpoint blockade and nanosonosensitizer- augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice

Wenwen Yue et al.

NATURE COMMUNICATIONS (2019)

添加到收藏夹

Review Nanoscience & Nanotechnology

Cancer nanomedicine for combination cancer immunotherapy

Jutaek Nam et al.

NATURE REVIEWS MATERIALS (2019)

添加到收藏夹

Article Chemistry, Multidisciplinary

Enzyme-Driven Membrane-Targeted Chimeric Peptide for Enhanced Tumor Photodynamic Immunotherapy

Chi Zhang et al.

ACS NANO (2019)

添加到收藏夹

Article Chemistry, Multidisciplinary

CSF1R-and SHP2-Inhibitor-Loaded Nanoparticles Enhance Cytotoxic Activity and Phagocytosis in Tumor-Associated Macrophages

Anujan Ramesh et al.

ADVANCED MATERIALS (2019)

添加到收藏夹

Review Oncology

Improving cancer immunotherapy through nanotechnology

Michael S. Goldberg

NATURE REVIEWS CANCER (2019)

添加到收藏夹

Review Chemistry, Multidisciplinary

Recent advances in nanomaterial-based synergistic combination cancer immunotherapy

Wei Sang et al.

CHEMICAL SOCIETY REVIEWS (2019)

添加到收藏夹

Article Chemistry, Multidisciplinary

Enhanced Immunotherapy Based on Photodynamic Therapy for Both Primary and Lung Metastasis Tumor Eradication

Wen Song et al.

ACS NANO (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors

Leila Dardaei et al.

NATURE MEDICINE (2018)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Induced protein degradation: an emerging drug discovery paradigm

Ashton C. Lai et al.

NATURE REVIEWS DRUG DISCOVERY (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases

Ying-Nan P. Chen et al.

NATURE (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy

Chunbai He et al.

NATURE COMMUNICATIONS (2016)

添加到收藏夹

Review Biotechnology & Applied Microbiology

SCF ubiquitin ligase-targeted therapies

Jeffrey R. Skaar et al.

NATURE REVIEWS DRUG DISCOVERY (2014)

添加到收藏夹

Review Cell Biology

Diversity of degradation signals in the ubiquitin-proteasome system

Tommer Ravid et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.